copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Interroll Portec Specialty Conveyors Airport Baggage and Parcel Handling The Interroll Portec Belt Curve can be found in airports throughout the world It is a hard-working, dependable piece of machinery loved by maintenance personnel because it requires very little attention The Interroll Portec Belt Curve helps maintain product spacing and orientation throughout the entire turn
PORTEC-4a at ESTRO 2025: International randomised trial of molecular . . . Vienna, Austria — A major international clinical trial, PORTEC-4a, has demonstrated that molecular profiling can safely reduce the use of radiotherapy for women with early-stage endometrial cancer, while identifying those who may benefit from more intensive treatment
Is the PORTEC 4a trial exploring too little and too late? In the PORTEC 4a study,1 the authors evaluate adjuvant external beam radiation and vaginal brachytherapy in stage I and II endometrial cancer However, the molecular classification of endometrial cancer has changed the paradigm of treatment across the stages
Molecular Profiling May Optimize Treatment for Endometrial Cancer A major international study, PORTEC-4a, provides evidence that molecular profiling may safely reduce the need for radiotherapy in some women with early-stage endometrial cancer while identifying those who would benefit from more intensive treatment
PORTEC-4a: international randomized trial of molecular profile-based . . . Background: Vaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life
Instant Oncology: PORTEC-3 - Clinical Oncology Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial